מונטהלוקאסט אינובמד 10 מ"ג

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

MONTELUKAST AS SODIUM 10 MG

Verfügbar ab:

INOVAMED LTD

ATC-Code:

R03DC03

Darreichungsform:

FILM COATED TABLETS

Verabreichungsweg:

PER OS

Hergestellt von:

SYNTHON B.V., NETHERLANDS

Therapiegruppe:

MONTELUKAST

Anwendungsgebiete:

Montelukast Inovamed is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.Montelukast Inovamed is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast Inovamed and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast Inovamed is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and adolescents 15 years of age and older.

Berechtigungsdatum:

2012-05-01